Xcellerex fast-tracks second single-use bioprocessing facility

Xcellerex has started construction on a cGMP biomanufacturing facility based on its portable FlexFactory platform, which incorporates the company's single-use technology. The project, at the company's Massachusetts headquarters location, is projected to be complete in September. The facility will be the company's second at that location. Release (.pdf)

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.